hypothesis glutathione persister cells Targeting PPP1R15B and ATF4 axis in hepatocellular carcinoma: A novel strategy for overcoming lenvatinib-tolerant through GPX4-mediated ferroptosis induction Exploiting phenotypic heterogeneity to improve
Exploiting phenotypic heterogeneity to improve production of glutathione by yeast Microbial Cell Factories Springer Nature Link Drug tolerant persister cancer cells are vulnerable to GPX4 inhibition Nature Frontiers Cysteine Depletion, a Key Action to Challenge Cancer Cells to Ferroptotic Cell Death Frontiers Glutathione Peroxidase 4 as a Therapeutic Target for Anti Colorectal Cancer Drug Tolerant Persister Cells Drug tolerant persister cancer cells are vulnerable to GPX4 inhibition PMC
Pay in 4 interest-free payments of $5.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




